Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Causes and impact of delays during the COVID-19 pandemic on head and neck cancer diagnosis.
Gete M, Huang SH, Ringash J, Irish J, Su J, Ballal Y, Waldron JN, Witterick I, de Almeida J, Hosni A, Hope AJ, Monteiro E, Cho J, O'Sullivan B, Kim J, Bratman S, Goldstein DP, McPartlin A, Tsai J, Tong L, Xu W, Hahn E. Gete M, et al. Among authors: mcpartlin a. Head Neck. 2024 Apr 25. doi: 10.1002/hed.27784. Online ahead of print. Head Neck. 2024. PMID: 38665037
Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based Model.
Watson EE, Hueniken K, Lee J, Huang SH, Maghrabi A AE, Xu W, Moreno AC, Tsai CJ, Hahn E, McPartlin AJ, Yao CM, Goldstein DP, De Almeida JR, Waldon JN, Fuller CD, Hope AJ, Ruggiero SL, Glogauer M, Hosni AA. Watson EE, et al. Among authors: mcpartlin aj. medRxiv [Preprint]. 2023 Sep 13:2023.09.12.23295454. doi: 10.1101/2023.09.12.23295454. medRxiv. 2023. PMID: 37745576 Free PMC article. Updated. Preprint.
Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model.
Watson E EE, Hueniken K, Lee J, Huang SH, El Maghrabi A, Xu W, Moreno AC, Tsai CJ, Hahn E, McPartlin AJ, Yao CMKL, Goldstein DP, De Almeida JR, Waldon JN, Fuller CD, Hope AJ, Ruggiero SL, Glogauer M, Hosni AA. Watson E EE, et al. Among authors: mcpartlin aj. J Clin Oncol. 2024 May 1:JCO2301951. doi: 10.1200/JCO.23.01951. Online ahead of print. J Clin Oncol. 2024. PMID: 38691822
Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer.
Gaffney J, Ramzan A, Dinizulu T, Maley C, Onamusi O, Motamedi-Ghahfarokhi G, Price G, Metcalf R, Garcez K, Hughes C, Lee L, Thomson D, Price J, Jain Y, McPartlin A. Gaffney J, et al. Among authors: mcpartlin a. Oral Oncol. 2024 Jan;148:106645. doi: 10.1016/j.oraloncology.2023.106645. Epub 2023 Nov 22. Oral Oncol. 2024. PMID: 37992488
Trial of Solanezumab in Preclinical Alzheimer's Disease.
Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team. Sperling RA, et al. N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17. N Engl J Med. 2023. PMID: 37458272 Free PMC article. Clinical Trial.
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy.
Li W, Padayachee J, Navarro I, Winter J, Dang J, Raman S, Kong V, Berlin A, Catton C, Glicksman R, Malkov V, McPartlin A, Kataki K, Lindsay P, Chung P. Li W, et al. Among authors: mcpartlin a. Tech Innov Patient Support Radiat Oncol. 2023 May 13;27:100212. doi: 10.1016/j.tipsro.2023.100212. eCollection 2023 Sep. Tech Innov Patient Support Radiat Oncol. 2023. PMID: 37265510 Free PMC article.
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer.
Dubec MJ, Buckley DL, Berks M, Clough A, Gaffney J, Datta A, McHugh DJ, Porta N, Little RA, Cheung S, Hague C, Eccles CL, Hoskin PJ, Bristow RG, Matthews JC, van Herk M, Choudhury A, Parker GJM, McPartlin A, O'Connor JPB. Dubec MJ, et al. Among authors: mcpartlin a. Radiother Oncol. 2023 Jun;183:109592. doi: 10.1016/j.radonc.2023.109592. Epub 2023 Mar 3. Radiother Oncol. 2023. PMID: 36870608 Free article.
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.
Thomson DJ, Cruickshank C, Baines H, Banner R, Beasley M, Betts G, Bulbeck H, Charlwood F, Christian J, Clarke M, Donnelly O, Foran B, Gillies C, Griffin C, Homer JJ, Langendijk JA, Lee LW, Lester J, Lowe M, McPartlin A, Miles E, Nutting C, Palaniappan N, Prestwich R, Price JM, Roberts C, Roe J, Shanmugasundaram R, Simões R, Thompson A, West C, Wilson L, Wolstenholme J, Hall E. Thomson DJ, et al. Among authors: mcpartlin a. Clin Transl Radiat Oncol. 2022 Nov 21;38:147-154. doi: 10.1016/j.ctro.2022.11.010. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36452431 Free PMC article.
45 results